Clinical Trial Update: Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluating AVE1642 for advanced or metastatic liver carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AVE1642

Snippet

Sponsor: Sanofi | Conditions: Liver Carcinoma | Phase 1, Phase 2 | Status: TERMINATED